Minocyclin in Ulcerative Colitis as Added on Therapy
Conditions: Inflammatory Bowel Diseases Interventions: Drug: Mesalazine; Drug: Minocycline Sponsors: Mostafa Bahaa; Amira Fawzy Mohamed Mashaly, Clinical Pharmacy Demonstrator, Faculty of Pharmacy- Horus University; Sahar Kamal Hegazi clinical pharmacy department, Tanta University; Mounir Hussein Bahgat Internal Medicine Department Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 11, 2024 Category: Research Source Type: clinical trials
Ulcerative Colitis Leukocyte TRAfficking After Treatment With Zeposia: the ULTRAZ Study
Conditions: Ulcerative Colitis Interventions: Drug: Ozanimod Oral Capsule Sponsors: Geert D ' Haens; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.
Conditions: Colitis, Ulcerative Interventions: Drug: Mesalazine Sponsors: Faes Farma, S.A. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
Clinical Outcome of Treatment of Ulcerative Colitis in Adult
Conditions: Ulcerative Colitis Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
The IBD-FITT study — moderate-intensity exercise for patients with inflammatory bowel disease with moderate disease activity: an open-label randomized controlled trial
DiscussionThis will be a clinical trial investigating the effect of exercise on patients with Crohn ’s disease and ulcerative colitis. This trial will add to the evidence on the possible effect of exercise and might clarify whether exercise can benefit as a supplementary treatment addendum. Thus, the trial may provide a new patient-active disease management approach.Trial registrationClinicalTrials.gov NCT04816812. Date of first registration: March 23, 2021. (Source: Trials)
Source: Trials - November 20, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Conditions: Ulcerative Colitis Interventions: Drug: Vixarelimab; Drug: Placebo Sponsors: Genentech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 17, 2023 Category: Research Source Type: clinical trials
A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)
Conditions: Ulcerative Colitis Interventions: Drug: Rosnilimab; Drug: Placebo Sponsors: AnaptysBio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants
Conditions: Ulcerative Colitis Interventions: Drug: Ozanimod; Drug: Conventional therapy; Drug: Advanced therapy Sponsors: Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Machine Learning Approach to Study the Interactions Between Environment and Intestinal Tissue Homeostasis in IBD
Conditions: Diabetes Mellitus, Type 1; Ulcerative Colitis Interventions: Other: Environmental factor monitoring; collection of blood, feces and urine. For UC: collection of 8 additional biopsies Sponsors: IRCCS San Raffaele Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
Conditions: Crohn Disease; Ulcerative Colitis Interventions: Drug: Adalimumab-680LT; Other: Control Sponsors: University Medical Center Groningen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Pilot Study of a New Medical Food in the Management of Ulcerative Colitis
Conditions: Ulcerative Colitis Interventions: Dietary Supplement: Soluble protein hydrolysate (SPHi) Sponsors: Stanford University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
The Mind-Body IBD Study: Understanding the Mind-body Connection in IBD
Conditions: Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis; Crohn Colitis Interventions: Other: Data collection Sponsors: King ' s College London; Medical Research Council Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2023 Category: Research Source Type: clinical trials
Subcutaneous Infliximab After A Previous Intravenous Dose Optimization
Conditions: Inflammatory Bowel Diseases; Crohn Disease; Ulcerative Colitis Interventions: Drug: Infliximab; Drug: Infliximab; Drug: Infliximab Sponsors: Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW; Celltrion Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
P2a Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
Conditions: Ulcerative Colitis Interventions: Biological: ALTB-268 Sponsors: AltruBio Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
Efficacy/Safety of ALTB-268 in Subjects w/Moderately to Severely Active UC Refractory to Biologics
Conditions: Ulcerative Colitis Interventions: Biological: ALTB-268 Sponsors: AltruBio Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
